Sign in Welcome! Log into your account your username your password Forgot your password? Get help Password recovery Recover your password your email A password will be e-mailed to you. AgilVax Appoints Dr. Joseph Patti as Chief Executive Officer By Admin July 25, 2019 NewslettersLook Who’s On the Move! Share Facebook Twitter Pinterest WhatsApp Linkedin Email Print ALBUQUERQUE, N.M.–(BUSINESS WIRE)–#biotech–AgilVax Appoints Dr. Joseph Patti as Chief Executive Officer…. http://www.businesswire.com/news/home/20190725005188/en/AgilVax-Appoints-Dr.-Joseph-Patti-Chief-Executive/ First Name * Email * Last Name * Country * Lists 02_NEWSLETTER: ANNOUNCEMENTS 02_NEWSLETTER: BIOTECHNOLOGY 02_NEWSLETTER: EDITOR´S PICK 02_NEWSLETTER: FEATURED ARTICLE 02_NEWSLETTER: HOSPITAL NEWS 02_NEWSLETTER: INDUSTRY NEWS 02_NEWSLETTER: LOOK WHO IS ON THE 02_NEWSLETTER: MEDICAL DEVICES 03_NEWSLETTER: NATALIE YEADON 02_NEWSLETTER: REGULATORY AFFAIRS 02_NEWSLETTER: CLINICAL TRIALS Recent Articles Who’s Getting Vaccinated in the US? Editor´s Pick April 9, 2021 Candel Therapeutics Appoints Chris Matheny, PharmD, Ph.D., as Vice President, Development Leader Look Who’s On the Move! April 9, 2021 Moderna Highlights Publication of Antibody Persistence Data of its COVID-19 Vaccine out to 6 Months in the New England Journal of Medicine Industry News April 8, 2021 FDA Approves Trodelvy®, the First Treatment for Metastatic Triple-Negative Breast Cancer Shown to Improve Progression-Free Survival and Overall Survival Look Who’s On the Move! April 8, 2021 Teva receives EU Marketing Authorisation for Seffalair® Spiromax® and BroPair® Spiromax® (salmeterol xinafoate / fluticasone propionate) Regulatory Affairs April 8, 2021 Sign in / Join
